The novel treatment of the medication represents a major development in the care of type 2 diabetes. Unlike existing medications, tirzepatide affects two pathways – the GLP-1 hormone and GIP – providing enhanced https://tirzepatidepeptide819658.xzblogs.com/82367975/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment